These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 37139340)

  • 21. Comparison of the Efficacy of Glucagon-Like Peptide-1 Receptor Agonists in Patients With Metabolic Associated Fatty Liver Disease: Updated Systematic Review and Meta-Analysis.
    Dai Y; He H; Li S; Yang L; Wang X; Liu Z; An Z
    Front Endocrinol (Lausanne); 2020; 11():622589. PubMed ID: 33664710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Global epidemiology of type 2 diabetes in patients with NAFLD or MAFLD: a systematic review and meta-analysis.
    Cao L; An Y; Liu H; Jiang J; Liu W; Zhou Y; Shi M; Dai W; Lv Y; Zhao Y; Lu Y; Chen L; Xia Y
    BMC Med; 2024 Mar; 22(1):101. PubMed ID: 38448943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Global Prevalence and Clinical Characteristics of Metabolic-associated Fatty Liver Disease: A Meta-Analysis and Systematic Review of 10 739 607 Individuals.
    Chan KE; Koh TJL; Tang ASP; Quek J; Yong JN; Tay P; Tan DJH; Lim WH; Lin SY; Huang D; Chan M; Khoo CM; Chew NWS; Kaewdech A; Chamroonkul N; Dan YY; Noureddin M; Muthiah M; Eslam M; Ng CH
    J Clin Endocrinol Metab; 2022 Aug; 107(9):2691-2700. PubMed ID: 35587339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between the severity of metabolic dysfunction-associated fatty liver disease and the risk of colorectal neoplasm: a systematic review and meta-analysis.
    Zeng Y; Cao R; Tao Z; Gao Y
    Lipids Health Dis; 2022 Jun; 21(1):52. PubMed ID: 35668493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meta-analysis of omega-3 polyunsaturated fatty acids on immune functions and nutritional status of patients with colorectal cancer.
    Yue T; Xiong K; Deng J; Hu W; Tan T; Li S; Yang T; Xiao T
    Front Nutr; 2022; 9():945590. PubMed ID: 36479293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic dysfunction-associated fatty liver disease and liver function markers are associated with Crohn's disease but not Ulcerative Colitis: a prospective cohort study.
    Chen J; Dan L; Tu X; Sun Y; Deng M; Chen X; Hesketh T; Li R; Wang X; Li X
    Hepatol Int; 2023 Feb; 17(1):202-214. PubMed ID: 36194337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does aerobic exercise reduce NASH and liver fibrosis in patients with non-alcoholic fatty liver disease? A systematic literature review and meta-analysis.
    Houttu V; Bouts J; Vali Y; Daams J; Grefhorst A; Nieuwdorp M; Holleboom AG
    Front Endocrinol (Lausanne); 2022; 13():1032164. PubMed ID: 36407307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimating Global Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease in Overweight or Obese Adults.
    Liu J; Ayada I; Zhang X; Wang L; Li Y; Wen T; Ma Z; Bruno MJ; de Knegt RJ; Cao W; Peppelenbosch MP; Ghanbari M; Li Z; Pan Q
    Clin Gastroenterol Hepatol; 2022 Mar; 20(3):e573-e582. PubMed ID: 33618024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating retinol binding protein 4 levels in nonalcoholic fatty liver disease: a systematic review and meta-analysis.
    Zhou Z; Chen H; Ju H; Sun M
    Lipids Health Dis; 2017 Sep; 16(1):180. PubMed ID: 28931435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic Associated Fatty Liver Disease Increases the Risk of Systemic Complications and Mortality. A Meta-Analysis and Systematic Review of 12 620 736 Individuals.
    Quek J; Ng CH; Tang ASP; Chew N; Chan M; Khoo CM; Wei CP; Chin YH; Tay P; Lim G; Tan DJH; Lim WH; Chan KE; Teng M; Tan E; Tamaki N; Huang DQ; Siddiqui MS; Young DY; Noureddin M; Muthiah MD
    Endocr Pract; 2022 Jul; 28(7):667-672. PubMed ID: 35364328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating Adipokine Levels in Nonobese Women With Polycystic Ovary Syndrome and in Nonobese Control Women: A Systematic Review and Meta-Analysis.
    Lin K; Sun X; Wang X; Wang H; Chen X
    Front Endocrinol (Lausanne); 2020; 11():537809. PubMed ID: 33488512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Association of Metabolic-Associated Fatty Liver Disease with Clinical Outcomes of COVID-19: A Systematic Review and Meta-Analysis.
    Hayat U; Ashfaq MZ; Johnson L; Ford R; Wuthnow C; Kadado K; El Jurdi K; Okut H; Kilgore WR; Assi M; Siddiqui AA
    Kans J Med; 2022; 15():241-246. PubMed ID: 35899064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between metabolic dysfunction-associated steatotic liver disease and risk of incident pancreatic cancer: a systematic review and meta-analysis of cohort studies.
    Zhang Y; Zhou BG; Zhan JD; Du BB
    Front Oncol; 2024; 14():1366195. PubMed ID: 38567158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resistin and omentin in breast cancer: A systematic review and meta-analysis.
    Zoroddu S; Di Lorenzo B; Paliogiannis P; Mangoni AA; Carru C; Zinellu A
    Clin Chim Acta; 2024 Jul; 562():119838. PubMed ID: 38972537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating tumor necrosis factor-α levels in non-alcoholic fatty liver disease: A systematic review and a meta-analysis.
    Potoupni V; Georgiadou M; Chatzigriva E; Polychronidou G; Markou E; Zapantis Gakis C; Filimidou I; Karagianni M; Anastasilakis D; Evripidou K; Ftergioti A; Togkaridou M; Tsaftaridis N; Apostolopoulos A; Polyzos SA
    J Gastroenterol Hepatol; 2021 Nov; 36(11):3002-3014. PubMed ID: 34289181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Serum Bilirubin With Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
    Liang C; Yu Z; Bai L; Hou W; Tang S; Zhang W; Chen X; Hu Z; Duan Z; Zheng S
    Front Endocrinol (Lausanne); 2022; 13():869579. PubMed ID: 35937795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of Severe COVID-19 Increased by Metabolic Dysfunction-associated Fatty Liver Disease: A Meta-analysis.
    Tao Z; Li Y; Cheng B; Zhou T; Gao Y
    J Clin Gastroenterol; 2021 Nov-Dec 01; 55(10):830-835. PubMed ID: 34406175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The efficacy and safety of Chinese herbal medicine as an add-on therapy for type 2 diabetes mellitus patients with carotid atherosclerosis: An updated meta-analysis of 27 randomized controlled trials.
    Zhang Z; Leng Y; Chen Z; Fu X; Liang Q; Peng X; Xie H; Gao H; Xie C
    Front Pharmacol; 2023; 14():1091718. PubMed ID: 37033624
    [No Abstract]   [Full Text] [Related]  

  • 39. The Role of Thyroid Hormones and Autoantibodies in Metabolic Dysfunction Associated Fatty Liver Disease: TgAb May Be a Potential Protective Factor.
    Zhang X; Li R; Chen Y; Dai Y; Chen L; Qin L; Cheng X; Lu Y
    Front Endocrinol (Lausanne); 2020; 11():598836. PubMed ID: 33363517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of complement components with the risk and severity of NAFLD: A systematic review and meta-analysis.
    Zhao J; Wu Y; Lu P; Wu X; Han J; Shi Y; Liu Y; Cheng Y; Gao L; Zhao J; Wang Z; Fan X
    Front Immunol; 2022; 13():1054159. PubMed ID: 36569882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.